Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Factors Associated with Student Pharmacists' Academic Progression and Performance on the National Licensure Examination.

Spivey CA, Chisholm-Burns MA, Johnson JL.

Am J Pharm Educ. 2020 Feb;84(2):7561. doi: 10.5688/ajpe7561.

2.

Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies.

Spivey CA, Wilder A, Chisholm-Burns MA, Stallworth S, Wheeler J.

J Am Pharm Assoc (2003). 2020 Mar 4. pii: S1544-3191(20)30051-0. doi: 10.1016/j.japh.2020.01.030. [Epub ahead of print]

PMID:
32146134
3.

Analysis of Educational Debt and Income Among Pharmacists and Other Health Professionals.

Chisholm-Burns MA, Spivey CA, Stallworth S, Zivin JG.

Am J Pharm Educ. 2019 Nov;83(9):7460. doi: 10.5688/ajpe7460.

4.

Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis.

Spivey CA, Winthrop KL, Griffith J, Kaplan CM, Qiao Y, Postlethwaite AE, Wang J.

Rheumatol Ther. 2020 Mar;7(1):133-147. doi: 10.1007/s40744-019-00184-5. Epub 2019 Nov 18.

5.

Development of an Instrument to Measure Academic Resilience Among Pharmacy Students.

Chisholm-Burns MA, Spivey CA, Sherwin E, Williams J, Phelps S.

Am J Pharm Educ. 2019 Aug;83(6):6896. doi: 10.5688/ajpe6896.

6.

Impact of Pharmacy School Characteristics on NAPLEX First-time Pass Rates.

Williams JS, Spivey CA, Hagemann TM, Phelps SJ, Chisholm-Burns M.

Am J Pharm Educ. 2019 Aug;83(6):6875. doi: 10.5688/ajpe6875.

7.

The opioid crisis: Origins, trends, policies, and the roles of pharmacists.

Chisholm-Burns MA, Spivey CA, Sherwin E, Wheeler J, Hohmeier K.

Am J Health Syst Pharm. 2019 Mar 19;76(7):424-435. doi: 10.1093/ajhp/zxy089. Review.

PMID:
31361827
8.

Use of virtual patient software to assess student confidence and ability in communication skills and virtual patient impression: A mixed-methods approach.

Borja-Hart NL, Spivey CA, George CM.

Curr Pharm Teach Learn. 2019 Jul;11(7):710-718. doi: 10.1016/j.cptl.2019.03.009. Epub 2019 Mar 23.

PMID:
31227094
9.

Examining the Association of GPA and PCAT Scores on Objective Structured Clinical Examination Scores.

Williams JS, Metcalfe A, Shelton CM, Spivey CA.

Am J Pharm Educ. 2019 May;83(4):6608. doi: 10.5688/ajpe6608.

10.

Examination of Factors Relating to Student Performance on the Pharmacy Curriculum Outcomes Assessment.

McDonough SLK, Spivey CA, Chisholm-Burns MA, Williams JS, Phelps SJ.

Am J Pharm Educ. 2019 Mar;83(2):6516. doi: 10.5688/ajpe6516.

11.

Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues.

Qiao Y, Spivey CA, Wang J, Shih YT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

J Pharm Health Serv Res. 2018 Dec;9(4):393-401. doi: 10.1111/jphs.12266. Epub 2018 Sep 7.

12.

Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.

Spivey CA, Qiao Y, Wang J, Shih YT, Wan JY, Dagogo-Jack S, Cushman WC, Hines LE, Chisholm-Burns MA.

J Am Geriatr Soc. 2019 Mar;67(3):581-587. doi: 10.1111/jgs.15754. Epub 2019 Jan 23.

13.

Health literacy in solid-organ transplantation: a model to improve understanding.

Chisholm-Burns MA, Spivey CA, Pickett LR.

Patient Prefer Adherence. 2018 Nov 6;12:2325-2338. doi: 10.2147/PPA.S183092. eCollection 2018. Review.

14.

Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.

Qiao Y, Spivey CA, Wang J, Shih YT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns MA.

Inquiry. 2018 Jan-Dec;55:46958018795749. doi: 10.1177/0046958018795749.

15.

Report from the American Society of Transplantation Psychosocial Community of Practice Adherence Task Force: Real-world options for promoting adherence in adult recipients.

Myaskovsky L, Jesse MT, Kuntz K, Leino AD, Peipert JD, Russell CL, Spivey CA, Sulejmani N, Dew MA.

Clin Transplant. 2018 Sep;32(9):e13353. doi: 10.1111/ctr.13353. Epub 2018 Aug 9. Review.

16.

Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.

Spivey CA, Wang J, Qiao Y, Shih YT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

J Manag Care Spec Pharm. 2018 Feb;24(2):97-107. doi: 10.18553/jmcp.2018.24.2.97.

17.

A community-based partnership collaborative practice agreement project to teach innovation in care delivery.

Hohmeier KC, Spivey CA, Chisholm-Burns M.

Curr Pharm Teach Learn. 2017 May;9(3):473-478. doi: 10.1016/j.cptl.2017.02.004. Epub 2017 Apr 14.

PMID:
29233287
18.

A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States.

Spivey CA, Griffith J, Kaplan C, Postlethwaite A, Ganguli A, Wang J.

Rheumatol Ther. 2018 Jun;5(1):255-270. doi: 10.1007/s40744-017-0089-8. Epub 2017 Dec 4.

19.

Associations Between Pharmacy Students' Attitudes Toward Debt, Stress, and Student Loans.

Chisholm-Burns MA, Spivey CA, Jaeger MC, Williams J.

Am J Pharm Educ. 2017 Sep;81(7):5918. doi: 10.5688/ajpe8175918.

20.

Implementation of a health information exchange into community pharmacy workflow.

Hohmeier KC, Spivey CA, Boldin S, Moore TB, Chisholm-Burns M.

J Am Pharm Assoc (2003). 2017 Sep - Oct;57(5):608-615. doi: 10.1016/j.japh.2017.05.009. Epub 2017 Jul 18.

PMID:
28733155
21.

Examining the Association Between the NAPLEX, Pre-NAPLEX, and Pre- and Post-admission Factors.

Chisholm-Burns MA, Spivey CA, Byrd DC, McDonough SLK, Phelps SJ.

Am J Pharm Educ. 2017 Jun;81(5):86. doi: 10.5688/ajpe81586.

22.

Development of an Instrument to Measure Pharmacy Student Attitudes Toward Social Media Professionalism.

Chisholm-Burns MA, Spivey CA, Jaeger MC, Williams J, George C.

Am J Pharm Educ. 2017 May;81(4):65. doi: 10.5688/ajpe81465.

23.

Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services.

Chisholm-Burns MA, Spivey CA, Gatwood J, Wiss A, Hohmeier K, Erickson SR.

Am J Health Syst Pharm. 2017 May 15;74(10):653-668. doi: 10.2146/ajhp150872. Epub 2017 Apr 4.

PMID:
28377378
24.

Women in leadership and the bewildering glass ceiling.

Chisholm-Burns MA, Spivey CA, Hagemann T, Josephson MA.

Am J Health Syst Pharm. 2017 Mar 1;74(5):312-324. doi: 10.2146/ajhp160930. Epub 2017 Jan 25. Review. No abstract available.

PMID:
28122701
25.

Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Wang J, Qiao Y, Spivey CA, Li C, Clark C, Deng Y, Liu F, Tillman J, Chisholm-Burns M.

J Pharm Health Serv Res. 2016 Dec;7(4):209-215. doi: 10.1111/jphs.12142. Epub 2016 May 26.

26.

Net Income of Pharmacy Faculty Compared to Community and Hospital Pharmacists.

Chisholm-Burns MA, Gatwood J, Spivey CA, Dickey SE.

Am J Pharm Educ. 2016 Sep 25;80(7):117.

27.

Medication therapy management and adherence among US renal transplant recipients.

Chisholm-Burns MA, Spivey CA, Tolley EA, Kaplan EK.

Patient Prefer Adherence. 2016 Apr 28;10:703-9. doi: 10.2147/PPA.S104646. eCollection 2016.

28.

Break-Even Income Analysis of Pharmacy Graduates Compared to High School and College Graduates.

Chisholm-Burns MA, Gatwood J, Spivey CA, Dickey SE.

Am J Pharm Educ. 2016 Apr 25;80(3):44. doi: 10.5688/ajpe80344.

29.

Factors Associated with Student Pharmacist Philanthropy to the College Before and After Graduation.

Chisholm-Burns MA, Spivey CA.

Am J Pharm Educ. 2015 Sep 25;79(7):102. doi: 10.5688/ajpe797102.

30.

Economic Analysis of Obtaining a PharmD Degree and Career as a Pharmacist.

Chisholm-Burns MA, Gatwood J, Spivey CA.

Am J Pharm Educ. 2015 Oct 25;79(8):117. doi: 10.5688/ajpe798117.

31.

Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.

Wang J, Qiao Y, Shih YC, Jarrett-Jamison J, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

J Manag Care Spec Pharm. 2015 Nov;21(11):993-1003.

32.

Stroke associated with discontinuation of warfarin therapy for atrial fibrillation.

Spivey CA, Liu X, Qiao Y, Mardekian J, Parker RB, Phatak H, Masseria C, Kachroo S, Abdulsattar Y, Wang J.

Curr Med Res Opin. 2015 Nov;31(11):2021-9. doi: 10.1185/03007995.2015.1082995. Epub 2015 Sep 21.

PMID:
26390258
33.

Trends in Medicare Part D Medication Therapy Management Eligibility Criteria.

Wang J, Shih YC, Qin Y, Young T, Thomas Z, Spivey CA, Solomon DK, Chisholm-Burns M.

Am Health Drug Benefits. 2015 Jul-Aug;8(5):247-55.

34.

Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.

Spivey CA, Qiao Y, Liu X, Mardekian J, Parker RB, Phatak H, Claflin AB, Kachroo S, Abdulsattar Y, Chakrabarti A, Wang J.

J Manag Care Spec Pharm. 2015 Jul;21(7):596-606.

35.

Evaluation of student factors associated with pre-NAPLEX scores.

Chisholm-Burns MA, Spivey CA, McDonough S, Phelps S, Byrd D.

Am J Pharm Educ. 2014 Dec 15;78(10):181. doi: 10.5688/ajpe7810181.

36.

Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.

Wang J, Qiao Y, Shih YC, Jamison JJ, Spivey CA, Li L, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

Am Health Drug Benefits. 2014 Sep;7(6):346-58.

37.

Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.

Wang J, Surbhi S, Zhang Z, Spivey CA, Chisholm-Burns M.

Res Social Adm Pharm. 2014 Nov-Dec;10(6):904-917. doi: 10.1016/j.sapharm.2014.02.007. Epub 2014 Mar 2.

38.

Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups.

Wang J, Qiao Y, Shih YC, Jamison JJ, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M.

Value Health. 2014 Nov;17(7):A789. doi: 10.1016/j.jval.2014.08.426. Epub 2014 Oct 26. No abstract available.

39.

Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation.

Wang J, Qiao Y, Spivey CA, Liu X, Phatak H, Mardekian J, Claflin AB, Kachroo S, Abdulsatter Y, Parker RB.

Value Health. 2014 Nov;17(7):A763. doi: 10.1016/j.jval.2014.08.272. Epub 2014 Oct 26. No abstract available.

40.

Health Care Utilization and Costs After Warfarin Discontinuation Among Patients with Non-Valvular Atrial Fibrillation.

Wang J, Qiao Y, Spivey CA, Liu X, Phatak H, Mardekian J, Claflin AB, Kachroo S, Abdulsatter Y, Parker RB.

Value Health. 2014 Nov;17(7):A756. doi: 10.1016/j.jval.2014.08.230. Epub 2014 Oct 26. No abstract available.

41.

Burden among male Alzheimer's caregivers: effects of distinct coping strategies.

Geiger JR, Wilks SE, Lovelace LL, Chen Z, Spivey CA.

Am J Alzheimers Dis Other Demen. 2015 May;30(3):238-46. doi: 10.1177/1533317514552666. Epub 2014 Sep 28.

PMID:
25267930
42.

Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.

Wang J, Qiao Y, Tina Shih YC, Spivey CA, Dagogo-Jack S, Wan JY, White-Means SI, Cushman WC, Chisholm-Burns MA.

J Pharm Health Serv Res. 2014 Jun;5(2):109-118.

43.

Serving underserved transplant recipients: experience of the Medication Access Program.

Spivey CA, Chisholm-Burns MA, Garrett C, Duke KM.

Patient Prefer Adherence. 2014 May 2;8:613-9. doi: 10.2147/PPA.S63133. eCollection 2014.

44.

Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients.

Spivey CA, Chisholm-Burns MA, Damadzadeh B, Billheimer D.

Clin Transplant. 2014 Jan;28(1):96-104. doi: 10.1111/ctr.12283. Epub 2013 Dec 11.

PMID:
24329814
45.

Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial.

Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA.

Am J Transplant. 2013 Sep;13(9):2364-73. doi: 10.1111/ajt.12341. Epub 2013 Jul 2.

46.

The 'cost' of medication nonadherence: consequences we cannot afford to accept.

Chisholm-Burns MA, Spivey CA.

J Am Pharm Assoc (2003). 2012;52(6):823-6. doi: 10.1331/JAPhA.2012.11088.

PMID:
23229971
47.

Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients.

Chisholm-Burns MA, Spivey CA, Sredzinski E, Butler SL.

J Am Pharm Assoc (2003). 2012;52(6):816-22. doi: 10.1331/JAPhA.2012.11083.

PMID:
23229970
48.

Multi-institutional study of women and underrepresented minority faculty members in academic pharmacy.

Chisholm-Burns MA, Spivey CA, Billheimer D, Schlesselman LS, Flowers SK, Hammer D, Engle JP, Nappi JM, Pasko MT, Ross LA, Sorofman B, Rodrigues HA, Vaillancourt AM.

Am J Pharm Educ. 2012 Feb 10;76(1):7. doi: 10.5688/ajpe7617.

49.

Concurrent validity of kidney transplant questionnaire in US renal transplant recipients.

Chisholm-Burns MA, Erickson SR, Spivey CA, Gruessner RW, Kaplan B.

Patient Prefer Adherence. 2011;5:517-22. doi: 10.2147/PPA.S24261. Epub 2011 Oct 13.

50.

Health-related quality of life and employment among renal transplant recipients.

Chisholm-Burns MA, Erickson SR, Spivey CA, Kaplan B.

Clin Transplant. 2012 May-Jun;26(3):411-7. doi: 10.1111/j.1399-0012.2011.01541.x. Epub 2011 Oct 28.

PMID:
22032257

Supplemental Content

Loading ...
Support Center